Medifast
MED
123 hedge funds and large institutions have $126M invested in Medifast in 2025 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 24 reducing their positions, and 17 closing their positions.
9,297% more call options, than puts
Call options by funds: $29.6M | Put options by funds: $315K
83% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 24
18% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 17
5.56% more ownership
Funds ownership: 78.45% → 84.01% (+5.6%)
3% more funds holding
Funds holding: 120 → 123 (+3)
4% more capital invested
Capital invested by funds: $121M → $126M (+$5.04M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lido Advisors
Los Angeles,
California
|
+$4.62M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$2.43M |
| 3 |
Morgan Stanley
New York
|
+$1.83M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.27M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$886K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.46M |
| 2 |
Millennium Management
New York
|
-$1.3M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.08M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$825K |
| 5 |
D.E. Shaw & Co
New York
|
-$804K |
MED Hedge Fund Activity: Q3 2025 in Review
123 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q3 2025, worth a combined $126M — up 4.2% from $121M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new MED positions and 17 closed out — a net gain of 3 holders — while 44 added to existing stakes and 24 trimmed.
The largest buyer was Lido Advisors, opening a new position worth an estimated $4.62M. The largest seller was Vanguard Group, cutting an estimated $1.46M.
- 123 institutional investors held Medifast (MED) as of Q3 2025, up from 120 in Q2 2025.
- Funds reported $126M of Medifast stock for Q3 2025, up 4.2% quarter-over-quarter.
- 20 funds opened new Medifast positions in Q3 2025 and 17 closed out, a net change of +3 holders.
- The largest Medifast buyer in Q3 2025 was Lido Advisors, an estimated $4.62M added.
- The largest Medifast seller in Q3 2025 was Vanguard Group, an estimated $1.46M sold.
Based on aggregated 13F filings for Q3 2025.